These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3371394)

  • 1. The antianginal efficacy and tolerability of controlled-release metoprolol once daily: a comparison with conventional metoprolol tablets twice daily.
    Egstrup K; Gundersen T; Härkönen R; Karlsson E; Lundgren B
    Eur J Clin Pharmacol; 1988; 33 Suppl():S45-9. PubMed ID: 3371394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metoprolol in angina pectoris complicated by essential hypertension. A clinical comparison of the antianginal efficacy of metoprolol slow-release tablets (Durules) given once daily and propranolol tablets given twice daily.
    BLoem TJ; Lindner PC
    Ann Clin Res; 1981; 13 Suppl 30():61-7. PubMed ID: 6794420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of angina pectoris with metoprolol. A comparison between Durules administered once daily and tablets administered twice daily.
    Orö L
    Ann Clin Res; 1981; 13 Suppl 30():58-60. PubMed ID: 6794419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conventional and controlled release diltiazem. Bioavailability in healthy volunteers and anti-anginal effects in combination with metoprolol in stable angina pectoris.
    Brorson L; Arvill A; Löfdahl P; Jörgensen E; Fraser T; Larsson H; Olsson AM; Olsson SO
    Eur J Clin Pharmacol; 1994; 47(1):75-9. PubMed ID: 7988629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of controlled-release metoprolol on blood pressure and exercise heart rate in hypertension: a comparison with conventional tablets.
    Rydén L; Kristensson BE; Westergren G
    Eur J Clin Pharmacol; 1988; 33 Suppl():S33-7. PubMed ID: 3371392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of a new controlled-release formulation of metoprolol: a comparison with conventional metoprolol tablets in mild to moderate hypertension.
    Houtzagers JJ; Smilde JG; Creytens G; Westergren G
    Eur J Clin Pharmacol; 1988; 33 Suppl():S39-44. PubMed ID: 3371393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of metoprolol OROS with antenolol in the treatment of effort angina pectoris: a randomized double-blind study.
    Floris B; Paoletti G; Pelizza L; Bertulla A; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1991 Apr; 29(4):139-43. PubMed ID: 1906434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK once daily with conventional tablets once daily and in divided doses.
    Lücker P; Moore G; Wieselgren I; Olofsson B; Bergstrand R
    J Clin Pharmacol; 1990 Feb; 30(S2):S17-27. PubMed ID: 2312775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metoprolol, nifedipine, and the combination in stable effort angina pectoris.
    Uusitalo A; Arstila M; Bae EA; Härkönen R; Keyriläinen O; Rytkönen U; Schjelderup-Mathiesen PM; Wendelin H
    Am J Cardiol; 1986 Apr; 57(10):733-7. PubMed ID: 3083664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of a controlled release (CR/ZOK) formulation of metoprolol, once daily, with conventional metoprolol tablets, twice daily, in mild to moderate hypertension.
    Carruthers G; Shearer R; Taylor W; Moore M
    J Clin Pharmacol; 1990 Feb; 30(S2):S61-5. PubMed ID: 2179282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: a comparison with conventional tablets.
    Sandberg A; Blomqvist I; Jonsson UE; Lundborg P
    Eur J Clin Pharmacol; 1988; 33 Suppl():S9-14. PubMed ID: 3371395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antianginal efficacy of the combination of felodipine-metoprolol 10/100 mg compared with each drug alone in patients with stable effort-induced angina pectoris: a multicenter parallel group study. The TRAFFIC Study Group.
    Emanuelsson H; Egstrup K; Nikus K; Ellström J; Glud T; Pater C; Scheibel M; Tisell A; Tötterman KJ; Forsby M
    Am Heart J; 1999 May; 137(5):854-62. PubMed ID: 10220634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Slow-release metoprolol in angina pectoris. A comparative study of a cardioselective beta-blocking drug, metoprolol, in ordinary and slow-release tablets (Durules) in the treatment of angina pectoris.
    Uusitalo AJ; Keyriläinen O
    Ann Clin Res; 1979 Oct; 11(5):199-204. PubMed ID: 44671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.
    Plosker GL; Clissold SP
    Drugs; 1992 Mar; 43(3):382-414. PubMed ID: 1374320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacokinetic and pharmacodynamic comparison of immediate-release metoprolol and extended-release metoprolol CR/XL in patients with suspected acute myocardial infarction: a randomized, open-label study.
    Karlson BW; Dellborg M; Gullestad L; Aberg J; Sugg J; Herlitz J
    Cardiology; 2014; 127(2):73-82. PubMed ID: 24247812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Felodipine versus placebo in stable effort-induced angina pectoris in patients inadequately controlled with metoprolol--a dose-finding study.
    Emanuelsson H; Ahlström P; Kujacic V; Lundkvist L; Rosenqvist U; Tisell A; Angman K
    J Cardiovasc Pharmacol; 1994 Aug; 24(2):303-9. PubMed ID: 7526065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antianginal effect of conventional and controlled release diltiazem in stable angina pectoris.
    Boman K; Saetre H; Karlsson LG; Ritter B; Marsell R; Wingman H; Lövheim O; Michaeli EW; Löfdahl P; Olsson SO
    Eur J Clin Pharmacol; 1995; 49(1-2):27-30. PubMed ID: 8751017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand.
    Szwed H; Sadowski Z; Elikowski W; Koronkiewicz A; Mamcarz A; Orszulak W; Skibińska E; Szymczak K; Swiatek J; Winter M
    Eur Heart J; 2001 Dec; 22(24):2267-74. PubMed ID: 11728147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once- versus twice-daily administration of controlled-release isosorbide-5-mononitrate 60 mg in the treatment of stable angina pectoris. A randomized, double-blind, cross-over study. The Swedish Multicentre Group.
    Nordlander R; Walter M
    Eur Heart J; 1994 Jan; 15(1):108-13. PubMed ID: 8174569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of safety and efficacy of carvedilol and metoprolol in stable angina pectoris.
    van der Does R; Hauf-Zachariou U; Pfarr E; Holtbrügge W; König S; Griffiths M; Lahiri A
    Am J Cardiol; 1999 Mar; 83(5):643-9. PubMed ID: 10080412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.